 |
cyclic pyranopterin monophosphate (cPMP) |
|---|---|
| Trade Name | |
| Orphan Indication | Molybdenum cofactor deficiency type A (MoCD) |
| USA Market Approval | USA |
| USA Designation Date | 2009-11-05 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 |
